NASDAQ:AVXL
Anavex Life Sciences Corp.
- Stock
Last Close
4.50
17/05 20:00
Market Cap
511.70M
Beta: 0.75
Volume Today
942.30K
Avg: 1.09M
PE Ratio
−8.31
PFCF: −16.52
Sep '13 | Sep '14 | Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | ||||||||||||
cash per share | 0.04 - | 0.74 1,612.26% | 0.82 11.08% | 0.26 68.24% | 0.67 157.10% | 0.51 23.57% | 0.45 11.66% | 0.50 10.80% | 2.18 333.56% | 1.94 11.00% | 1.89 2.40% | |
company equity multiplier | -0.16 - | 38.18 23,999.70% | 1.21 96.84% | 1.51 24.68% | 1.15 23.77% | 1.19 3.64% | 1.25 4.94% | 1.27 1.59% | 1.07 15.50% | 1.07 0.01% | 1.09 1.56% | |
days of inventory outstanding | ||||||||||||
days of payables outstanding | ||||||||||||
days of sales outstanding | ||||||||||||
dividend yield | ||||||||||||
ebit per revenue | ||||||||||||
ebt per ebit | 1.73 - | 3.83 120.73% | 1.70 55.52% | 0.99 41.96% | 0.86 12.77% | 0.91 5.06% | 0.91 0.63% | 0.85 6.36% | 0.90 5.18% | 0.88 2.50% | 1 14.23% | |
effective tax rate | -0.01 - | -0.00 95.51% | -0.01 851.29% | -0.00 66.05% | -0.00 120.89% | -0.00 5.90% | -0.00 25.09% | -0.00 72.47% | -0.01 723.55% | -0.01 5.91% | 0.00 101.96% | |
enterprise value multiple | -9.64 - | -0.51 94.75% | -7.40 1,363.02% | -7.87 6.37% | -9.10 15.56% | -4.82 47.00% | -4.58 4.97% | -7.58 65.45% | -26.41 248.34% | -12.87 51.27% | -7.82 39.21% | |
fixed asset turnover | ||||||||||||
free cash flow per share | -0.10 - | -0.27 178.58% | -0.23 16.24% | -0.26 15.53% | -0.22 15.97% | -0.28 27.62% | -0.38 34.45% | -0.37 3.44% | -0.44 19.00% | -0.32 27.60% | -0.35 10.50% | |
gross profit margin | ||||||||||||
interest coverage | -41.55 - | -418.81 908.09% | -98.97 76.37% | -1.31 98.67% | -57.44 - | -49.27 14.22% | ||||||
inventory turnover | ||||||||||||
long term debt to capitalization | 0.97 - | 0.00 100.00% | ||||||||||
net income per ebt | 1 - | 1 0% | 1 0% | 1.00 0.20% | 1.00 0.24% | 1.00 0.03% | 1.00 0.10% | 1.00 0.23% | 1.01 0.62% | 1.01 0.04% | 1.00 0.76% | |
net profit margin | ||||||||||||
operating cash flow per share | -0.10 - | -0.27 178.26% | -0.23 16.15% | -0.26 15.53% | -0.22 15.97% | -0.28 27.62% | -0.38 34.45% | -0.37 3.44% | -0.44 19.00% | -0.32 27.60% | -0.35 10.50% | |
operating profit margin | ||||||||||||
payables turnover | ||||||||||||
pretax profit margin | ||||||||||||
price fair value | -8.42 - | 37.46 544.91% | 8.18 78.16% | 20.23 147.20% | 6.97 65.54% | 5.62 19.35% | 7.62 35.47% | 9.72 27.63% | 8.31 14.54% | 5.57 32.95% | 3.68 33.86% | |
receivables turnover | ||||||||||||
return on assets | -9.40 - | -1.55 83.56% | -0.78 49.37% | -1.55 98.22% | -0.48 68.83% | -0.72 48.08% | -1.04 44.99% | -0.76 26.71% | -0.23 69.17% | -0.31 33.95% | -0.31 2.09% | |
return on capital employed | 1.37 - | -0.50 136.71% | -0.55 10.51% | -2.36 324.95% | -0.64 72.83% | -0.94 46.13% | -1.42 51.36% | -1.13 20.31% | -0.28 75.39% | -0.38 37.34% | -0.33 12.29% | |
return on equity | 1.50 - | -59.02 4,028.96% | -0.95 98.40% | -2.34 147.14% | -0.55 76.24% | -0.85 53.47% | -1.30 52.16% | -0.96 25.55% | -0.25 73.95% | -0.34 33.96% | -0.33 0.57% | |
total debt to capitalization | -0.09 - | 0.97 1,134.45% | 0.01 99.31% |
All numbers in USD (except ratios and percentages)